Home › Research › Laboratory science
Clonal expansion of cytotoxic CD8⁺ T cells in lecanemab-associated ARIA
Johnson LA, Saito K, Pallerla AV, Funnell JL, Ezzo AR, Song CM, Harrison DA, Norton NJ, Moore LC, Van Eldik LJ, et al.. Nature Communications, 2026-01-30
Topic: Brain proteins, microglia and lab models
Plain-language summary
Amyloid-related imaging abnormalities (ARIA) are the principal safety concern limiting anti-amyloid therapies for Alzheimer's disease, yet their biology remains unclear. Here we show, through multi-omic profiling of peripheral blood from three ARIA+ patients and matched controls, that ARIA is associated with coordinated reprogramming of CD8 + T cells. CD8+ effector memory (TEM) and terminally differentiated (TEMRA) subsets were expanded, clonally enriched, and transcriptionally primed for cytotoxicity and vascular trafficking. Transcription factor inference and metabolomics converged on glycolytic reprogramming favoring short-lived effector function. Ligand-receptor modeling revealed enhanced monocyte-to-T cell signaling through antigen presentation, adhesion, and chemokine axes, while integration with a cerebrovascular atlas confirmed that ARIA-associated TEMRAs are transcriptionally "addressed" for vascular engagement. Together, these findings identify a peripheral immune signature linking metabolic reprogramming, clonal CD8+ expansion, and altered intercellular communication to ARIA, with implications for biomarker development and risk mitigation pending validation in larger cohorts.
What this study adds
Evidence grade: Preliminary
This is a case-control study of 3 participants. This small case-control study of three patients with amyloid-related imaging abnormalities (ARIA) found that ARIA was associated with coordinated reprogramming of CD8+ T cells. Its stated limit: Only three ARIA cases; peripheral blood rather than brain tissue; correlational; requires validation in larger cohorts before any clinical use.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Johnson, L. A., Saito, K., Pallerla, A. V., Funnell, J. L., Ezzo, A. R., Song, C. M., et al. (2026). Clonal expansion of cytotoxic CD8⁺ T cells in lecanemab-associated ARIA. Nature Communications. https://doi.org/10.1038/s41467-026-68921-3
Vancouver
Johnson LA, Saito K, Pallerla AV, Funnell JL, Ezzo AR, Song CM, et al. Clonal expansion of cytotoxic CD8⁺ T cells in lecanemab-associated ARIA. Nature Communications. 2026. doi:10.1038/s41467-026-68921-3. PMID: 41617706.
BibTeX
@article{johnson2026-41617706,
author = {Johnson, L. A. and Saito, K. and Pallerla, A. V. and Funnell, J. L. and Ezzo, A. R. and Song, C. M. and Harrison, D. A. and Norton, N. J. and Moore, L. C. and Van Eldik, L. J. and others},
title = {{Clonal expansion of cytotoxic CD8⁺ T cells in lecanemab-associated ARIA}},
journal = {Nature Communications},
year = {2026},
doi = {10.1038/s41467-026-68921-3},
pmid = {41617706},
url = {https://doi.org/10.1038/s41467-026-68921-3}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Here we show, through multi-omic profiling of peripheral blood from three ARIA+ patients and matched controls, that ARIA is associated with coordinated reprogramming of CD8 + T cells.
- Ligand-receptor modeling revealed enhanced monocyte-to-T cell signaling through antigen presentation, adhesion, and chemokine axes, while integration with a cerebrovascular atlas confirmed that ARIA-associated TEMRAs are transcriptionally "addressed" for vascular engagement.
- Together, these findings identify a peripheral immune signature linking metabolic reprogramming, clonal CD8+ expansion, and altered intercellular communication to ARIA, with implications for biomarker development and risk mitigation pending validation in larger cohorts.
Why it matters
This small case-control study of three patients with amyloid-related imaging abnormalities (ARIA) found that ARIA was associated with coordinated reprogramming of CD8+ T cells. The authors say these findings identify a peripheral immune signature with implications for biomarker development and risk mitigation, pending validation in larger cohorts.
Study details
- Study designcase-control
- Participants3
- Evidence strengthPreliminary
Limitations
Only three ARIA cases; peripheral blood rather than brain tissue; correlational; requires validation in larger cohorts before any clinical use.
How this study scored 53/100
Published in a leading specialty journal, and it is a case-control study. Scored zero for effect reported and randomized / blinded because the record does not state it. We have no data on free to read, so that was left out: it earned 52 of the 98 points we could judge it on, which is 53 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Nature Communications) |
| Journal's citation record | 4 / 4 | Nature Communications: journal h-index 747 (OpenAlex, 2026-10-29) |
| Study design | 6 / 12 | A case-control study |
| Strength of evidence | 2 / 5 | Rated “preliminary” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 1 / 4 | 3 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 2 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.0 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 4 / 6 | Cited 8.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Josh M. Morganti: h-index 23 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Kentucky: institution h-index 824 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41617706) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 52 / 98 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 52 of the 98 points we could judge it on is 53 out of 100. |
| Total | 53 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — PubMed Central lists this copy as free to read: the link above (checked 10 Oct 2026).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Laboratory science from nearby years
Also tagged “tdp-43”
1,150 studies in the library carry the topic tag “tdp-43”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,150 tagged studies.